Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine vs Patching for Moderate Amblyopia
NCT00000170Phase 3Completed
- Sponsor
- Jaeb Center for Health Research
- Start
- Apr 1999
- Primary completion
- Nov 2001
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of atropine in amblyopia (2 arms), sponsored by Jaeb Center for Health Research. Primary endpoint: Visual acuity in the amblyopic eye at 6 months. Started Apr 1999; status: completed.
02
Drugs
atropine
03
Conditions
amblyopia
Beyond the preview
Go deeper on NCT00000170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000170.